Moreover, in vitro studies in post-MI-rodents, reported that increased cardiac FGF23 expression drives cardiac fibrosis via activation of β-catenin which is a well-known pro-fibrotic factor that interacts with TGF- β signaling [30]. Here, FGF23 is linked to fibrosis.